Twitter
Facebook
LinkedIn
Heat Biologics, Inc.
Home
About
Management Team
Board of Directors
Scientific Advisory Board
Biothreat Advisory Board
Pelican Therapeutics
Technology
gp96 Platform
Pelican’s PTX-35 Co-stimulatory Antibody
Product Pipeline
Overview
HS-110
HS-130
COVID-19 / Biodefense Initiative
PTX-35
Expanded Access
Scientific Publications
Investors
Overview
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Corporate Presentation
News & Media
News Releases
Events
Careers
Contact
Events
News & Media
News & Media
News Releases
Events
Heat Biologics Analyst and Investor Event
New York City
Feb 28, 2018 • 8:00am EDT
Audio
Webcast
